Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.745
+0.005 (0.29%)
Jan 30, 2025, 12:18 PM EST - Market open
Fortress Biotech Employees
Fortress Biotech had 186 employees as of December 31, 2023. The number of employees decreased by 1 or -0.53% compared to the previous year.
Employees
186
Change (1Y)
-1
Growth (1Y)
-0.53%
Revenue / Employee
$438,177
Profits / Employee
-$309,274
Market Cap
48.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
FBIO News
- 3 days ago - Fortress Biotech Announces First Patient Dosed in Phase 2 Clinical Trial of Triplex Vaccination in Stem Cell Donors to Reduce CMV Events in Recipients of HSCT - GlobeNewsWire
- 7 days ago - Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea - GlobeNewsWire
- 24 days ago - Sentynl Therapeutics Announces U.S. FDA Acceptance and Priority Review of New Drug Application for CUTX-101 (Copper Histidinate) Product Candidate for Treatment of Menkes Disease - PRNewsWire
- 24 days ago - Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Acceptance and Priority Review of NDA for CUTX-101 for Treatment of Menkes Disease - GlobeNewsWire
- 6 weeks ago - Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl) - GlobeNewsWire
- 2 months ago - Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 2 months ago - Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 2 months ago - Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire